Xencor
+$1.27 (+3.56%) As of 7:21 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.
About XNCR
Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
CEO
Bassil I. Dahiyat
Employees
202
Headquarters
Monrovia, California
Founded
1997
XNCR Key Statistics
Market cap
2.16B
Price-Earnings ratio
—
Dividend yield
—
Average volume
269.21K
High today
$36.97
Low today
$34.84
Open price
$35.60
Volume
129.84K
52 Week high
$58.35
52 Week low
$30.12
Analyst ratings
92%
of 12 ratings
Buy
91.7%
Hold
0%
Sell
8.3%
XNCR Earnings
-$0.69
-$0.17
$0.35
$0.87
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 23, After Hours